Hundreds Of Potential Drug Targets For Huntington's Disease Identified By Genome-Scale Study

Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify hundreds of "druggable" molecular targets linked to the toxicity associated with the devastating, ultimately fatal disease. The results from this unprecedented genome-scale screen in a human cell model of HD are published in the journal PLOS Genetics. MNT

No comments:

Post a Comment